We expect Amgen AMGN to beat expectations when it reports second-quarter 2025 results on Aug. 5 after market close. In the ...

Denali Therapeutics, Inc. (NASDAQ:DNLI) is one of the best oversold NASDAQ stocks to buy now. In a report released on July 7, Thomas Shrader from BTIG maintained a Buy rating on Denali Therapeutics, ...

Denali Therapeutics, Inc. DNLI announced that the FDA has accepted for review its biologics license application (BLA) for lead-pipeline candidate tividenofusp alfa. The BLA is seeking accelerated ...

Review Denali Therapeutics Inc (DNLI:XNAS) stock and the current sustainability and ESG risk rating to help with your investing decisions.

Alector’s 71% drop prompts a fresh look at its valuation, financials, and pipeline to gauge recovery prospects amid lingering ...

Find out if Denali Therapeutics Inc (DNLI:XNAS) stock is overpriced or undervalued based on Morningstar's evaluation. Assess the current comparison of market prices to the Fair Value of the ...

Sino ang karapat-dapat maparangalan bilang Gawad Lingkod Bayan ng Pangulo at Gawad Pagasa? This is the question posed to the ...

Max Kettner, chief multi-asset strategist at HSBC, appeared on CNBC to talk about the global markets amid trade tensions.